Bedfont ® Scientific Limited, a world leader in breath analysis, is calling for a wider adoption of Fractional exhaled Nitric Oxide (FeNO) testing to improve asthma management and reduce ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

The NObreath ® is a FeNO monitor which can be used to measure airway inflammation for the management and diagnosis of asthma. Recommended by NICE and conformed to ATS & ERS guidelines ...